Corporate ActionJul 27, 2026, 02:31 PM
Clinuvel Pharmaceuticals Files Cessation of Securities Notification
AI Summary
Clinuvel Pharmaceuticals Limited filed a Form 6-K with the SEC, reporting the submission of an "Appendix 3H - Notification of cessation of securities" to the Australian Securities Exchange. This notification, dated July 27, 2026, indicates a change in the company's issued share capital and was attached as Exhibit 99.1 to the SEC filing.
Key Highlights
- Clinuvel Pharmaceuticals filed an Appendix 3H.
- The filing is a "Notification of cessation of securities".
- Submitted to the Australian Securities Exchange on July 27, 2026.
- Included as Exhibit 99.1 in the Form 6-K.
Price Impact
More from CUVL